The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Discussions on raising age for free subway rides gain momentum

  • 3

    2-year work experience prerequisite lifted for foreign shipyard welders

  • 5

    US reaffirms nuclear security assurances to South Korea

  • 7

    Families of Itaewon victims on collision course with Seoul City

  • 9

    William Franklin Sands' diplomatic and undiplomatic views of late Joseon

  • 11

    Will KT, POSCO replace CEOs as Shinhan, Woori did?

  • 13

    Korea as sublime, strange, and familiar

  • 15

    TXT, Le Sserafim top Oricon album and singles chart

  • 17

    Chinese spy balloon 'transits' Latin America after first craft flies over US

  • 19

    Blinken scraps rare China trip over alleged spy balloon

  • 2

    INTERVIEWTati Gabrielle, actress of Korean, African-American descent, feels proud of her heritage

  • 4

    Families of Itaewon crowd stampede victims clash with police over installation of memorial altar

  • 6

    China expresses 'strong dissatisfaction' over US shooting down balloon

  • 8

    Opposition party takes to streets to protest prosecution probes into leader

  • 10

    Korean American Rep. Young Kim named chair of House Indo-Pacific subcommittee

  • 12

    US remains committed to using full range of capabilities to defend S. Korea: Blinken

  • 14

    US shoots down suspected Chinese spy balloon with a single missile

  • 16

    Wang Yi urges US to 'avoid misjudgment' over balloon controversy

  • 18

    President Yoon at odds with politician who helped him win election

  • 20

    Musk didn't defraud investors with 2018 Tesla tweets

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Mon, February 6, 2023 | 22:38
Contract manufacturing emerges as new opportunity for Korean bio firms
Contract manufacturing emerges as new opportunity for Korean bio firms
FRANKFURT - The CPHI exhibition has become a place for finding new growth engines for Yungjin Pharm, Daewon Pharmaceutical, Kyongbo Pharm and other small Korean bio companies as they actively try to attract new clients for their contract manufacturing organization (CMO) business, according to the companies, Wednesday.
Baek Byung-yeul | 2022-11-03 16:09
New CEO vows to make SK pharmteco leading CDMO player
New CEO vows to make SK pharmteco leading CDMO player
FRANKFURT - Joerg Ahlgrimm, the new CEO of SK pharmteco, vowed Tuesday that his goal as a chief executive is to make the SK Group's contract development and manufacturing organization (CDMO) company one of the best players in the global cell and gene therapy (CGT) CDMO business. “We have technological leadership in the CDMO field and my goal is to create a significant competi...
Baek Byung-yeul | 2022-11-02 16:45
Samsung Biologics highlights essentials for global pharma-CDMO partnerships
Samsung Biologics highlights essentials for global pharma-CDMO partnerships
FRANKFURT - Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO) company that develops and produces drugs for its clients, said demand for biomedicine will exceed supply from 2026, adding that finding the best partner to outsource production is becoming more important for global pharmaceutical companies, according to its executive, Tue...
Baek Byung-yeul | 2022-11-01 19:05
Celltrion seeks new partnerships at CPhI bio exhibition
Celltrion seeks new partnerships at CPhI bio exhibition
FRANKFURT - Celltrion, a Korea-based biopharmaceutical company, is seeking to secure new partnerships at the CPhI bio pharmaceutical exhibition by opening an independent booth, the company said Tuesday. The exhibition is held every year touring major European cities. This year's event is in Frankfurt, Germany, for three days through Thursday, providing opportunities for medic...
Baek Byung-yeul | 2022-11-01 16:35
Samsung Biologics seeks to expand partnerships at CPhI
Samsung Biologics seeks to expand partnerships at CPhI
FRANKFURT - Samsung Biologics and other biotechnology companies in Korea will showcase their technologies and seek more business opportunities with global buyers at this year's CPhI bio pharmaceutical exhibition, according to the companies, Monday. The CPhI is an annual exhibition in the bio pharmaceutical industry held in Europe. This year's event will be held for three days...
Baek Byung-yeul | 2022-10-31 15:36
HLB Science to showcase sepsis treatment at BIO-Europe
HLB Science to showcase sepsis treatment at BIO-Europe
HLB Science, an affiliate of HLB Group, said Friday that it will showcase its sepsis treatment to medical experts and buyers at the BIO-Europe conference, which will be held virtually from Nov. 2 to 4. BIO-Europe is one of the largest pharmaceutical conferences in the biotechnology industry where around 2,000 companies from over 60 countries participate every year to discuss ...
Baek Byung-yeul | 2022-10-28 14:50
SK Bioscience aims to address vaccine inequality through global partnership
SK Bioscience aims to address vaccine inequality through global partnership
SK Bioscience, which developed Korea's first COVID-19 vaccine, SKYCovione, said Thursday that the biotech company aims to address the issue of vaccine inequality by intensifying collaboration with international organizations so that people living in low-income countries will be easily able to prevent life-threatening diseases. Rich, developed countries were the first to get a...
Baek Byung-yeul | 2022-10-20 16:43
HLB completes preparatory meeting with FDA for approval of liver cancer drug
HLB completes preparatory meeting with FDA for approval of liver cancer drug
Local biotech company HLB is stepping up efforts to win a novel drug approval in the United States for its liver cancer treatment Rivoceranib, after completing a pre-new drug application (NDA) meeting with the U.S. Food and Drug Administration (FDA), the company said Wednesday. The company said its U.S. subsidiary Elevar Therapeutics and China's Jiangsu Hengrui Medicine compl...
Baek Byung-yeul | 2022-10-12 17:01
Samsung chief vows to invest $5.2 bil. to create huge lead for bio business
Samsung chief vows to invest $5.2 bil. to create huge lead for bio business
Samsung Electronics Vice Chairman Lee Jae-yong has vowed to invest 7.5 trillion won ($5.2 billion) in the company's biotechnology firm by 2032 to achieve a huge lead with its competitors, Samsung Group said Tuesday. The Samsung chief attended the ceremony for the completion of Samsung Biologics' fourth drug manufacturing plant in Songdo, Incheon. The plant, which went into op...
Baek Byung-yeul | 2022-10-11 16:47
Samsung Biologics launches bispecific antibody platform S-DUAL
Samsung Biologics launches bispecific antibody platform S-DUAL
Samsung Biologics launched S-DUAL, a bispecific antibody platform developed with its own technology with an aim to improve its capability in the contract-based drug development business, the company said Thursday. Bispecific antibodies act on two factors simultaneously, not just one factor, which is more effective than a monospecific antibody that acts on only one factor.
Baek Byung-yeul | 2022-10-06 16:46
1 2 34567
Top 10 Stories
12-year work experience prerequisite lifted for foreign shipyard welders 2-year work experience prerequisite lifted for foreign shipyard welders
2Families of Itaewon victims on collision course with Seoul City Families of Itaewon victims on collision course with Seoul City
3President Yoon at odds with politician who helped him win election President Yoon at odds with politician who helped him win election
49 fishermen, including 2 Vietnamese, missing in boat incident 9 fishermen, including 2 Vietnamese, missing in boat incident
5LG publishes Korea's first group-level net zero report LG publishes Korea's first group-level net zero report
6[VIDEO] Filipina K-pop idol and K-drama actress react to stereotypes about the Philippines VIDEOFilipina K-pop idol and K-drama actress react to stereotypes about the Philippines
7Conflict reignites over relocation of POSCO Holdings to Pohang Conflict reignites over relocation of POSCO Holdings to Pohang
8FSC approves security token transactions in Korea FSC approves security token transactions in Korea
9Hyundai Motor's technology helps team become WTCR double champion Hyundai Motor's technology helps team become WTCR double champion
10Tasks lie ahead for Woori's next chairman nominee picked amid controversy Tasks lie ahead for Woori's next chairman nominee picked amid controversy
DARKROOM
  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

  • World Cup 2022 France vs Morocco

    World Cup 2022 France vs Morocco

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group